高剂量格栅状放疗技术及应用

doi:10.3760/cma.j.issn.1004-4221.2018.06.019

摘要
图/表
参考文献()
相关文章 (4)
点击分布统计
下载分布统计

全文: PDF (0 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS) 背景资料

摘要

高剂量格栅状(Grid)放疗技术是通过格栅准直器或者MLC将照射野均匀分割成等间隔的小射线束,实施单次大剂量照射(10~25 Gy),在靶区内形成非均匀的高低剂量区,剂量学上表现为峰谷效应(peak-to-valley effect)。随着3DRT技术的出现,二维格栅状治疗技术演变为三维的点阵式(Lattice)治疗技术。它通过不同形式的三维聚焦,在肿瘤内部形成多个空间上呈点阵式分布的球状高剂量区,球状高剂量区之间的区域剂量迅速跌落,形成三维非均匀的适形剂量分布。和二维Grid技术相比较,三维Lattice技术可以产生更明显的峰谷效应,更大程度地降低了肿瘤周围正常组织的剂量。实验数据表明,该照射技术可以刺激旁观者效应,增加内皮细胞死亡和免疫原性远隔效应,从而增强对肿瘤细胞的杀灭,进一步提高对局部和远处肿瘤的控制。Lattice技术在中晚期大肿瘤的姑息治疗上有明显的潜力,但是仍需要更多放射生物学机制和临床数据的支持。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	李小波
	江柳清
	吴晓东
	张建平
	徐本华

关键词 ：高剂量, 格栅状, 点阵式, 大体积肿瘤, 大分割疗法

Abstract：

High dose grid radiotherapy (GRID) refers to a single fraction of high-dose radiation (10-25 Gy) in which, beams are divided into multiple small beam lets through a grid collimator or MLC, resulting in non-uniform dose distribution of high and low dose area (“peak-to-valley” effect) in the target volume. Recently, as 3D radiotherapy (3DRT) technology emerged, the 2D GRID has been reconfigured into 3D dose LATTICE whereby high doses are concentrated at each lattice vertex within the radiation target volume with drastically lower dose between vertices through multiple focused non-coplanar beams with different radiation techniques. Compared with 2D GRID therapy, 3D LATTICE shows significant effect on “peak-to-valley” and minimizes radiation to surrounding tissues.Experimental and clinical data have shown that LATTICE therapies can reduce toxicity to normal tissue while stimulating bystander effects, endothelial cell death and immunogenic abscopal effects leading to enhanced killing of tumor cells and further improve the control of the local and distant disease. The clinic experience with LATTICE, although limited, has demonstrated favorable outcomes, especially for treating bulky tumors and palliative intend. The exact mechanism of the clinical advantages by LATTICE is not explicitly known and a more comprehensive biological study and clinical trials are called should be carried out.

Key words： High dose Grid Lattice Bulky tumor Hypofractionation

收稿日期: 2017-09-14

基金资助:

福建省科技厅引导性项目(2016Y0044);福建省卫生和计划生育委员会医学创新课题(2016-CX-19)

通讯作者: 徐本华,Email:benhuaxu@163.com

引用本文:

李小波,江柳清,吴晓东等. 高剂量格栅状放疗技术及应用[J]. 中华放射肿瘤学杂志, 2018, 27(6): 624-628.

Li Xiaobo,Jiang Liuqing,Wu Xiaodong et al. The application of high-dose grid radiotherapy technique[J]. Chinese Journal of Radiation Oncology, 2018, 27(6): 624-628.

链接本文:

http://journal12.magtechjournal.com/Jweb_fszlx/CN/10.3760/cma.j.issn.1004-4221.2018.06.019 或 http://journal12.magtechjournal.com/Jweb_fszlx/CN/Y2018/V27/I6/624

[1] Reddy SP,Hong RL,Nagda S,et al. Effect of tumor bulk on local control and survival of patients with T1 glottic cancer:a 30-year experience[J].Int J Radiat Oncol BiolPhys,2007,69(5):1389-1394.DOI:10.1016/j.ijrobp.2007.05.077.
[2] Mohiuddin M,Fujita M,Regine W F,et al. High dose spatially fractionated radiation (GRID):a new paradigm in the management of advanced cancers[J].Int J Radiat Oncol Biol Phys,1999;51(3):721-727.DOI:10.1016/S0360-3016(99)00170-4.
[3] Mohiuddin M,Stevens JH,Reiff JE,et al. Spatially fractionated (GRID) radiation for palliative treatment of advanced cancer[J].Radiat Oncol Investig,2015,4(1):41-47.DOI:10.1002/(SICI)1520-6823(1996)4:1%3C41::AID-ROI7%3E3.0.CO;2-M.
[4] Laissue JA,Blattmann H,Slatkin DN.Alban Köhler (1874–1947):inventor of gridtherapy.[Z].Med Phys 2012,22:90-99.DOI:10.1016/j.zemedi.2011.07.002.
[5] Ha JK,Zhang G,Naqvi SA,et al. Feasibility of delivering grid therapy using a multileaf collimator[J].Med Phys,2006,33(1):76-82.DOI:10.1118/1.2140116.
[6] Schültke E,Balosso J,Breslin T,et al. Microbeam radiation therapy-grid therapy and beyond:a clinical perspective[J].Br J Radiol,2017,90(1078):20170073.DOI:10.1259/bjr.20170073.
[7] Nobah A,Mohiuddin M,Devic S,et al. Effective spatially fractionated GRID radiation treatment planning for a passive grid block[J].Br J Radiol,2015,88(1045):20140363.DOI:10.1259/bjr.20140363.
[8] Zhang H,Zhong H,Barth RF,et al. Impact of dose size in single fraction spatially fractionated (grid) radiotherapy for melanoma[J].Med Phys,2014,41(2):021727.DOI:10.1118/1.4862837.
[9] Wu X,Ahmed MM,Pollack A.On modern technical approaches of 3D high-dose lattice radiotherapy (LRT)[J].Cureus,2010,5(3):S723 DOI:10.7759/cureus.9.
[10] Jin JY,Zhao B,Kaminski JM,et al. A MLC-based inversely optimized 3D spatially fractionated grid radiotherapy technique[J].Radiother Oncol,2015,117(3):483-486.DOI:10.1016/j.radonc.2015.07.047.
[11] Amendola BE,Perez N,Amendola M,et al. Lattice radiotherapy with rapidarc for treatment of gynecological tumors:dosimetric and early clinical evaluations[J].Cureus,2010,2(9):e15.DOI:10.7759/cureus.15.
[12] Blanco SJ,Amendola BE,Perez N,et al. The use of lattice radiation therapy (LRT) in the treatment of bulky tumors:a case report of a large metastatic mixed mullerian ovarian tumor[J].Cureus,2015,7(11):e389.DOI 10.7759/cureus.389.
[13] Hopewell JW,Trott KR.Volume effects in radiobiology as applied to radiotherapy[J].Radiother Oncol,2000,56(3):283.DOI:10.1016/S0167-8140(00)00236-X.
[14] Jolles B.The study of connective-tissue reaction to radiation. The sieve or chess method[J].Br J Cancer,1949,3(1):27.DOI:10.1038/bjc.1949.3.
[15] Jolles B.X-ray Skin reactions and the protective role of normal tissues[J].Br J Radiol,2014(159):110-112.DOI:10.1259/0007-1285-14-159-110.
[16] Martínez-Rovira I,Fois G,Prezado Y.Dosimetric evaluation of new approaches in GRID therapy using nonconventional radiation sources[J].Med Phys,2015,42(2):685-693.DOI:10.1118/1.4905042.
[17] Prasanna A,Ahmed MM,Mohiuddin M,et al. Exploiting sensitization windows of opportunity in hyper and hypofractionated radiation therapy[J].Thoracic Dis 2014,6(4):287-302.DOI:10.3978/j.issn.2072-1439.2014.01.14.
[18] Qinghui Z,Suqing T,Giovanni B.A new definition of biological effective dose:The dose distribution effects[J].Phys Med,2015,31(8):1060-1064.DOI:10.1016/j.ejmp.2015.07.145.
[19] Shareef MM,Cui N,Burikhanov R,et al. Role of tumor necrosis factoralpha and TRAIL in high-dose radiation-induced bystander signaling in lung adenocarcinoma[J].Cancer Res,2007,67(24):11811-1120.DOI:10.1158/0008-5472.CAN-07-0722.
[20] Sathishkumar S,Dey S,Meigooni AS,et al. The impact of TNF-alpha induction on therapeutic efficacy following high dose spatially fractionated (GRID) radiation[J].Technol Cancer Res Treat,2002,1(2):141-147.DOI:10.1177/153303460200100207.
[21] Sathishkumar S,Boyanovsky B,Karakashian AA,et al. Elevated sphingomyelinase activity and ceramide concentration in serum of patients undergoing high dose spatially fractionated radiation treatment:implications for endothelial apoptosis[J].Cancer Biol Ter,2005,49(4):979-986.DOI:10.4161/cbt.4.9.1915.
[22] Lee Y,Auh SL,Wang Y,et al. Therapeutic effects of ablative radiation on local tumor require CD8+ T cells:changing strategies for cancer treatment[J].Blood,2009,114(3):589-595.DOI:10.1182/blood-2009-02-206870.
[23] Garcia-Barros M,Paris F,Cordon-Cardo C,et al. Tumor response to radiotherapy regulated by endothelial cell apoptosis[J].Science,2003,562(300):1155-1159.DOI:10.1126/science.1082504.
[24] Bao S,Wu Q,McLendon RE,et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response[J].Nature,2006,444(7120):756-760.DOI:10.1038/nature05236.
[25] Prise KM,O′Sullivan JM.Radiation-induced bystander signal ling in cancer therapy[J].Nat Rev Cancer,2009,9(5):351-360.DOI:10.1038/nrc2603.
[26] Djordjevic B.Bystander effects:a concept in need of clarification.[J].Bioessays,2000,22(3):286-290.DOI:10.1002/(SICI)1521-1878(200003)22:3<286::AID-BIES10>3.0.CO;2-S.
[27] Peters ME,Shareef MM,Gupta S,et al. Potential utilization of bystander/abscopal-mediated signal transduction events in the treatment of solid tumors[J].Curr Signal Transduct Ther,2007,2(2):129-143.DOI:10.2174/157436207780619509.
[28] Yu P,Man Z,Zheng L,et al. Cysteine protease cathepsin B mediates radiation-induced bystander effects[J].Nature,2017,547(7664):458.DOI:10.1038/nature23284.
[29] Schmid TE,Multhoff G.Non-targeted effects of photon and particle irradiation and the interaction with the immune system[J].Front Oncol,2012,2(1):80.DOI:10.3389/fonc.2012.00080.eCollection 2012.
[30] Formenti SC,Demaria S.Systemic effects of local radiotherapy[J].Lancet Oncol,2009,10(7):718-726.DOI:10.1016/S1470-2045(09)70082-8.
[31] Saravana K,Seema G,Xiaodong W,et al. In vivo effects of lattice radiation therapy on local and distant lung cancer:potential role of immunomodulation[J].Radiat Res,2014,182(2):149-62.DOI:10.1667/RR3819.1.Epub 2014 Jul 18.
[32] Marconi R,Strolin S,Bossi G,et al. A meta-analysis of theabscopal effect in preclinical models:Is the biologically effective dose a relevant physical trigger?[J/OL].Plos One,2017,12(2):e0171559.
[33] 刘思涵,田野,张大昕.大剂量分割放疗与肿瘤免疫——新概念与新结合[J].中华放射肿瘤学杂志,2016,25(7):777-781.DOI:10.3760/cma.j.issn.1004-4221.2016.07.025.
Liu SH,Tian Y,Zhang DX.Hypofractionated radiotherapy and tumor immunity-new concepts and new combination.[J]Chin J Radiat Oncol,2016,25(7):777-781.DOI:10.3760/cma.j.issn.1004-4221.2016.07.025.
[34] Gupta S,Zagurovskaya M,Wu X,et al. Spatially fractionated grid high dose radiation-induced tumor regression in A549 lung adenocarcinoma xenografts:cytokines and ceramide regulators balance in abscopal phenomena[M].Sylvie:Plac Syl Compreh Cancer Cent,2014:20.
[35] Meigooni AS,Kai D,Meigooni NJ,et al. Dosimetric characteristics of a newly designed grid block for megavoltage photon radiation and its therapeutic advantage using a linear quadratic model[J].Med Phys,2006,33(9):3165-3173.DOI:10.1118/1.2241998.
[36] Buckey C,Stathakis S,Cashon K,et al. Evaluation of a commercially-available block for spatially fractionated radiation therapy[J].J Appl Clin Med Phys,2010,11(3):3163.DOI:10.1120/jacmp.v11i3.3163.
[37] Gholami S,Nedaie HA,Longo F,et al. Is grid therapy useful for all tumors and every grid block design?[J].J Appl Clin Med Phys,2016,17(2):6015.DOI:10.11 20/jacmp.v17i2.6015.
[38] Zhu X,Driewer J,Li S,et al. Technical note:fabricating cerrobend grids with 3D printing for spatially modulated radiation therapy:a feasibility study[J].Med Phys,2015,42(11):6269.DOI:10.1118/1.4924780.
[39] Nolan MW,Gieger TL,Karakashian AA,et al. Outcomes of spatially fractionated radiotherapy (GRID) for bulky soft tissue sarcomas in a large animal model[J].Technol Cancer Res T,2017,16(3):357.DOI:10.1177/1533034617690980.
[40] Huhn JL,Regine WF,Valentino JP,et al. Spatially fractionated GRID radiation treatment of advanced neck disease associated with head and neck cancer[J].Technol Cancer Res Treat,2006,5(6):607-612.DOI:10.1177/153303460600500608.
[41] Penagaricano JA,Moros EG,Ratanatharathorn V,et al. Evaluation of spatially fractionated radiotherapy (GRID) and definitive chemoradiotherapy with curative intent for locally advanced squamous cell carcinoma of the head and neck:Initial response rates and toxicity[J].Int J Radiat Oncol Biol Phys,2010,76(5):1369-1375.DOI:10.1016/j.ijrobp.2009.03.030.
[42] Fu KK,Pajak TF,Trotti A,et al. A radiation therapy oncology group (RTOG) phase Ⅲ randomized studyto compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas:frst report of RTOG 9003[J].Int J Radiat Oncol Biol Phys,2000,48(1):7-16.DOI:10.1016/S1278-3218(00)00060-3.
[43] Mohiuddin M,Park H,Hallmeyer S,et al. High-dose radiation as a dramatic,immunological primer in locally advanced melanoma[J].Cureus,2014,7(12):e417.DOI:10.7759/cureus.417.